Alcon Inc. Stock price

Equities

ALC

CH0432492467

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 12:30:28 2024-03-28 pm EDT 5-day change 1st Jan Change
74.74 CHF -0.64% Intraday chart for Alcon Inc. -0.21% +13.86%
Sales 2024 * 9.99B 9.01B Sales 2025 * 10.65B 9.6B Capitalization 40.93B 36.89B
Net income 2024 * 933M 841M Net income 2025 * 1.21B 1.09B EV / Sales 2024 * 4.39 x
Net Debt 2024 * 2.89B 2.61B Net Debt 2025 * 1.67B 1.5B EV / Sales 2025 * 4 x
P/E ratio 2024 *
45.6 x
P/E ratio 2025 *
35.2 x
Employees 25,315
Yield 2024 *
0.35%
Yield 2025 *
0.4%
Free-Float 98.54%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.64%
1 week-0.21%
Current month-0.59%
1 month+5.36%
3 months+14.18%
6 months+6.47%
Current year+13.86%
More quotes
1 week
74.42
Extreme 74.42
75.80
1 month
74.42
Extreme 74.42
77.60
Current year
62.24
Extreme 62.24
77.60
1 year
61.28
Extreme 61.28
77.60
3 years
55.22
Extreme 55.22
81.40
5 years
38.63
Extreme 38.625
81.40
10 years
38.63
Extreme 38.625
81.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 16-06-30
Director of Finance/CFO 56 19-04-07
Chief Tech/Sci/R&D Officer - 11-05-31
Members of the board TitleAgeSince
Chairman 68 18-06-30
Director/Board Member 65 18-12-31
Director/Board Member 61 19-01-31
More insiders
Date Price Change Volume
24-03-28 74.74 -0.64% 730,358
24-03-27 75.22 +0.64% 569,299
24-03-26 74.74 -0.03% 695,529
24-03-25 74.76 -0.21% 373,849
24-03-22 74.92 -1.00% 558,291

Delayed Quote Swiss Exchange, March 28, 2024 at 12:30 pm EDT

More quotes
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
82.98 USD
Average target price
93.08 USD
Spread / Average Target
+12.17%
Consensus
  1. Stock
  2. Equities
  3. Stock Alcon Inc. - Swiss Exchange